Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Is the COVID-19 vaccine safe for children?

Pfizer’s vaccine has been authorized by U.S. regulators for younger children, and millions of teens already safely received the shot

Via AP news wire
Thursday 23 December 2021 05:24 GMT
Virus-Outbreak-Viral-Questions-Vaccine-Kids
Virus-Outbreak-Viral-Questions-Vaccine-Kids

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Is the COVID-19 vaccine safe for children?

Yes, U.S. regulators authorized Pfizer’s vaccine for younger children after millions of 12- to 17-year-olds already safely got the shot, the only one available for children in the country.

More than 5 million children ages 5 to 11 have gotten a first dose since early November, and government safety monitoring has not uncovered any surprise problems.

This age group gets kid-size doses of the Pfizer-BioNTech vaccine, a third of the amount used to vaccinate everyone 12 or older. The Food and Drug Administration cleared the shots based on a study showing the kid-size doses were 91% effective at preventing symptomatic COVID-19. The 5- to 11-year-olds developed virus-fighting antibodies as strong as those of teens and young adults who got regular doses, with similar or fewer annoying reactions such as sore arms, fever or achiness.

The FDA assessed the safety of the kid-size doses in 3,100 vaccinated youngsters. Regulators deemed that enough data, considering the trove of safety information from hundreds of millions of larger doses given to adults and teens worldwide.

Very rarely, teens and young adults given the Pfizer vaccine or a similar one made by Moderna experience a serious side effect, heart inflammation, or what doctors call myocarditis. It’s mostly in young men or teen boys, and usually after the second dose. They tend to recover quickly, and after intense scrutiny U.S. health authorities concluded the vaccine’s benefits outweigh that small risk.

The Centers for Disease Control and Prevention is looking into a handful of reports of heart inflammation, mostly mild and brief, among 5- to 11-year-olds since vaccinations of that age group began.

To put the risk in context, COVID-19 also causes heart inflammation, often a more severe kind, said Dr. Matthew Oster, a pediatric cardiologist at Emory University It also sometimes occurs in children who get a multisystem inflammatory syndrome after a coronavirus infection.

Before the pandemic, doctors regularly diagnosed heart inflammation caused by bacterial or viral infections or medications, again mostly in teen boys and young men. Oster said one theory is that testosterone and puberty play a role, which is partly why many experts expect any vaccine-related risk would be lower for younger kids getting a smaller dose.

___

The AP is answering your questions about the coronavirus in this series. Submit them at: FactCheck@AP.org. Read more here:

Can your pet get COVID-19?

How will the world decide when the pandemic is over?

How can I protect myself from the new omicron variant?

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in